BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

NOVAVAX, INC — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

NOVAVAX, INC

via NOVAVAX, INC

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 19, 2021Filing document ↗LDA record ↗

Expenses$120Kself-filed spend

Client

Name: NOVAVAX, INC
Location: Maryland · United States of America

Registrant

Firm: NOVAVAX, INC
Description: clinical-stage vaccine company
Location: Gaithersburg, Maryland, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to COVID-19 vaccines
LobbyistsKELLY CAPPIO · DANIELLE FREDERICKS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.